2178 related articles for article (PubMed ID: 27763550)
1. Age- and Brain Region-Specific Changes of Glucose Metabolic Disorder, Learning, and Memory Dysfunction in Early Alzheimer's Disease Assessed in APP/PS1 Transgenic Mice Using
Li XY; Men WW; Zhu H; Lei JF; Zuo FX; Wang ZJ; Zhu ZH; Bao XJ; Wang RZ
Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27763550
[TBL] [Abstract][Full Text] [Related]
2. Amyloid-beta deposition is associated with decreased hippocampal glucose metabolism and spatial memory impairment in APP/PS1 mice.
Sadowski M; Pankiewicz J; Scholtzova H; Ji Y; Quartermain D; Jensen CH; Duff K; Nixon RA; Gruen RJ; Wisniewski T
J Neuropathol Exp Neurol; 2004 May; 63(5):418-28. PubMed ID: 15198121
[TBL] [Abstract][Full Text] [Related]
3. Activation of brain glucose metabolism ameliorating cognitive impairment in APP/PS1 transgenic mice by electroacupuncture.
Liu W; Zhuo P; Li L; Jin H; Lin B; Zhang Y; Liang S; Wu J; Huang J; Wang Z; Lin R; Chen L; Tao J
Free Radic Biol Med; 2017 Nov; 112():174-190. PubMed ID: 28756309
[TBL] [Abstract][Full Text] [Related]
4. Thiamine diphosphate reduction strongly correlates with brain glucose hypometabolism in Alzheimer's disease, whereas amyloid deposition does not.
Sang S; Pan X; Chen Z; Zeng F; Pan S; Liu H; Jin L; Fei G; Wang C; Ren S; Jiao F; Bao W; Zhou W; Guan Y; Zhang Y; Shi H; Wang Y; Yu X; Wang Y; Zhong C
Alzheimers Res Ther; 2018 Mar; 10(1):26. PubMed ID: 29490669
[TBL] [Abstract][Full Text] [Related]
5. Effect of Chinese herbal compound GAPT on the early brain glucose metabolism of APP/PS1 transgenic mice.
Mana L; Feng H; Dong Y; Wang Y; Shi J; Tian J; Wang P
Int J Immunopathol Pharmacol; 2019; 33():2058738419841482. PubMed ID: 30957587
[TBL] [Abstract][Full Text] [Related]
6. The hypothalamus as the primary brain region of metabolic abnormalities in APP/PS1 transgenic mouse model of Alzheimer's disease.
Zheng H; Zhou Q; Du Y; Li C; Xu P; Lin L; Xiao J; Gao H
Biochim Biophys Acta Mol Basis Dis; 2018 Jan; 1864(1):263-273. PubMed ID: 29107091
[TBL] [Abstract][Full Text] [Related]
7. Electroacupuncture Enhances Cognition by Promoting Brain Glucose Metabolism and Inhibiting Inflammation in the APP/PS1 Mouse Model of Alzheimer's Disease: A Pilot Study.
Xu A; Tang Y; Zeng Q; Wang X; Tian H; Zhou Y; Li Z
J Alzheimers Dis; 2020; 77(1):387-400. PubMed ID: 32741819
[TBL] [Abstract][Full Text] [Related]
8. Age-related changes in brain metabolites and cognitive function in APP/PS1 transgenic mice.
Chen SQ; Cai Q; Shen YY; Wang PJ; Teng GJ; Zhang W; Zang FC
Behav Brain Res; 2012 Nov; 235(1):1-6. PubMed ID: 22828014
[TBL] [Abstract][Full Text] [Related]
9. Brain energy metabolism and neuroinflammation in ageing APP/PS1-21 mice using longitudinal
Takkinen JS; López-Picón FR; Al Majidi R; Eskola O; Krzyczmonik A; Keller T; Löyttyniemi E; Solin O; Rinne JO; Haaparanta-Solin M
J Cereb Blood Flow Metab; 2017 Aug; 37(8):2870-2882. PubMed ID: 27834284
[TBL] [Abstract][Full Text] [Related]
10. Glucose tolerance and insulin sensitivity are impaired in APP/PS1 transgenic mice prior to amyloid plaque pathogenesis and cognitive decline.
Macklin L; Griffith CM; Cai Y; Rose GM; Yan XX; Patrylo PR
Exp Gerontol; 2017 Feb; 88():9-18. PubMed ID: 28025127
[TBL] [Abstract][Full Text] [Related]
11. Increased regional cerebral glucose uptake in an APP/PS1 model of Alzheimer's disease.
Poisnel G; Hérard AS; El Tannir El Tayara N; Bourrin E; Volk A; Kober F; Delatour B; Delzescaux T; Debeir T; Rooney T; Benavides J; Hantraye P; Dhenain M
Neurobiol Aging; 2012 Sep; 33(9):1995-2005. PubMed ID: 22079157
[TBL] [Abstract][Full Text] [Related]
12. Detection by voxel-wise statistical analysis of significant changes in regional cerebral glucose uptake in an APP/PS1 transgenic mouse model of Alzheimer's disease.
Dubois A; Hérard AS; Delatour B; Hantraye P; Bonvento G; Dhenain M; Delzescaux T
Neuroimage; 2010 Jun; 51(2):586-98. PubMed ID: 20206704
[TBL] [Abstract][Full Text] [Related]
13. Effects of accelerated senescence on learning and memory, locomotion and anxiety-like behavior in APP/PS1 mouse model of Alzheimer's disease.
Lok K; Zhao H; Zhang C; He N; Shen H; Wang Z; Zhao W; Yin M
J Neurol Sci; 2013 Dec; 335(1-2):145-54. PubMed ID: 24095271
[TBL] [Abstract][Full Text] [Related]
14. Intranasal 15d-PGJ2 ameliorates brain glucose hypometabolism via PPARγ-dependent activation of PGC-1α/GLUT4 signalling in APP/PS1 transgenic mice.
Li Z; Zhang Y; Zheng Y; Liu W; Zhang X; Li W; Zhang D; Cai Q; Wang S; Meng X; Huang G
Neuropharmacology; 2021 Sep; 196():108685. PubMed ID: 34175325
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of Ubiquilin-1 Alleviates Alzheimer's Disease-Caused Cognitive and Motor Deficits and Reduces Amyloid-β Accumulation in Mice.
Adegoke OO; Qiao F; Liu Y; Longley K; Feng S; Wang H
J Alzheimers Dis; 2017; 59(2):575-590. PubMed ID: 28598849
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Neuropathological Effects of a High-Fat Diet in a Presymptomatic Alzheimer's Disease Stage in APP/PS1 Mice.
Ettcheto M; Petrov D; Pedrós I; Alva N; Carbonell T; Beas-Zarate C; Pallas M; Auladell C; Folch J; Camins A
J Alzheimers Dis; 2016 Jul; 54(1):233-51. PubMed ID: 27567882
[TBL] [Abstract][Full Text] [Related]
17. CART mitigates oxidative stress and DNA damage in memory deficits of APP/PS1 mice via upregulating β‑amyloid metabolism‑associated enzymes.
Jiang H; Niu F; Zheng Y; Xu Y
Mol Med Rep; 2021 Apr; 23(4):. PubMed ID: 33604684
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the APP/PS1 mouse model of Alzheimer's disease in senescence accelerated background.
Lok K; Zhao H; Shen H; Wang Z; Gao X; Zhao W; Yin M
Neurosci Lett; 2013 Dec; 557 Pt B():84-9. PubMed ID: 24176881
[TBL] [Abstract][Full Text] [Related]
19. Cerebral inoculation of human A53T α-synuclein reduces spatial memory decline and amyloid-β aggregation in APP/PS1 transgenic mice of Alzheimer's disease.
Hao YN; Lu QX; Zhai YH; Wang HY; Wu MN; Hu MM; Yang B; Wang ZJ; Wu ZW; Qi JS
Brain Res Bull; 2018 Oct; 143():116-122. PubMed ID: 30366065
[TBL] [Abstract][Full Text] [Related]
20. Effective expression of Drebrin in hippocampus improves cognitive function and alleviates lesions of Alzheimer's disease in APP (swe)/PS1 (ΔE9) mice.
Liu Y; Xu YF; Zhang L; Huang L; Yu P; Zhu H; Deng W; Qin C
CNS Neurosci Ther; 2017 Jul; 23(7):590-604. PubMed ID: 28597477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
